Business profile & competitive position
AMETEK, Inc. operates in the Industrials sector under the Electrical Equipment & Parts industry. In plain terms, it manufactures electronic instruments and electromechanical devices through two operating groups: Electronic Instruments (EIG) and Electromechanical (EMG). EIG produces advanced analytical, test and measurement instruments for process, aerospace, power and industrial markets, while EMG supplies precision motion control, medical components, thermal management systems, specialty metals and electrical interconnects to aerospace, defense, medical, automation and other industrial markets.
The company’s financial profile points to a business with meaningful pricing power and operational discipline. Its net margin is 20.0% and return on equity (ROE) is 14.5%. A 20.0% net margin is well above what most broad industrial companies post, and it is consistent with a portfolio of specialized, often mission-critical components and instruments where switching costs and engineering specification matter. The 14.5% ROE indicates that management allocates equity capital with reasonable efficiency, although that figure also reflects the company’s acquisition-heavy growth model. The beta of 0.99 means the stock has historically moved roughly in line with the overall market, which fits a mature, globally diversified industrial franchise.
Financial posture
AME currently carries a market capitalization around $55.4 billion and trades at a trailing P/E of 35.2. That multiple is a clear premium to the typical industrial stock and assumes continued execution rather than a recovery story. The high valuation is partly justified by the 20.0% net margin, the 14.5% ROE, and the consistent earnings track record, but it also leaves a narrow band for error if macro or end-market demand surprises to the downside.
Near-term technical context is neutral: as of the latest snapshot, AME is priced at $241.87, with an RSI of 52.1 and a 50-day EMA of $239.86, essentially hugging its short-term moving average. The combination of an above-average valuation and neutral technicals suggests the stock is priced for steady execution rather than cyclical rebound.
Strategic priorities & outlook
AMETEK’s most recent 10-K outlines a straightforward playbook: execute the AMETEK Growth Model, which targets high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. Operational excellence initiatives include lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens and the broader use of digitalization and artificial intelligence.
Acquisitions remain central to the strategy. From 2021 through December 31, 2025, AMETEK completed 15 acquisitions representing approximately $1.8 billion in annualized sales. In 2025 alone, the company spent $933.2 million, net of cash acquired, to purchase Kern (high-precision machining and optical inspection solutions) and FARO Technologies (3D measurement and imaging solutions). These deals fit the stated goal of expanding in adjacent markets tied to secular growth themes.
The company is also pushing geographic diversification through best-cost manufacturing in China, Czechia, Malaysia, Mexico and Serbia. In 2025, AMETEK generated $7,401.1 million in sales, up 6.6% from 2024, and posted diluted EPS of $6.40, up 7.9%. It also achieved record operating income, net income, orders and backlog. As of December 31, 2025, the company employed approximately 22,500 people.
Macro & geopolitical exposure
Because AMETEK sits in the Electrical Equipment & Parts industry, it is exposed to the global industrial capital spending cycle, aerospace and defense budgets, medical device demand, and automation trends. The business model amplifies two common macro risks for this group: currency translation and cross-border trade policy.
Nearly half of sales are generated outside the United States—52% of EIG net sales and 42% of EMG net sales in 2025. That means foreign exchange swings, regional economic slowdowns and tariffs can all influence reported results. The manufacturing footprint in China, Czechia, Malaysia, Mexico and Serbia provides customer proximity and cost advantages, but it also creates exposure to geopolitical shifts, local regulatory changes and supply-chain disruptions. Commodity input costs and transport availability are additional variables that generally affect electrical equipment suppliers.
Recent developments
Recent headlines show a mix of strategic expansion and post-earnings price pressure. On August 26, 2026, PR Newswire reported that AMETEK completed its acquisition of Indicor Instrumentation, continuing the active M&A streak detailed in its 10-K. On September 1, 2026, Seeking Alpha published “Ametek: The Quiet Control Layer Behind The Next Industrial Investment Cycle,” framing the company as a structural beneficiary of automation and industrial digitization.
Less optimistically, a Zacks article dated September 3, 2026, noted that AME had declined 8.5% since its last earnings report, a reminder that even companies with strong fundamental track records can experience sentiment-driven pullbacks. Separately, on September 4, 2026, Seeking Alpha reported that Baron SMID Cap ETF included AME in its second-quarter 2026 portfolio activity. Taken together, the news flow points to a company still upgrading its portfolio through deals but facing near-term selling pressure after a beat-and-flat earnings reaction.
Earnings behavior & post-earnings drift
AME has an unusually consistent earnings record: over the last eight reported quarters, it beat consensus estimates in all eight (100% beat rate) with an average earnings surprise of 4%. Yet consistent beats have not produced large post-announcement price drifts. The average five-day move following earnings across those eight quarters is just 0.46%, classified as flat.
The most recent four quarters illustrate the pattern. On August 4, 2026, AMETEK reported EPS of $2.09 versus a $1.99 estimate (a 5.0% surprise); the stock rose 0.28% the next day and 0.89% over the following five days. On April 30, 2026, EPS of $1.97 beat the $1.90 estimate by 3.7%, but the stock fell 2.13% the next day and 0.33% over five days. On February 3, 2026, EPS of $2.01 beat the $1.94 estimate by 3.6%, with a next-day decline of 0.48% but a five-day gain of 1.83%. On October 30, 2025, EPS of $1.89 beat the $1.76 estimate by 7.4%, rising 1.91% the next day before slipping 0.54% over the following week.
The takeaway is that the market increasingly treats AMETEK’s earnings beats as expected rather than surprising. The next scheduled report is October 29, 2026, before the market open, with the consensus EPS estimate at $2.11.
Frequently Asked Questions
What does AMETEK’s 8/8 earnings beat rate imply?
It signals very consistent execution against consensus estimates, with an average surprise of 4% over the last eight quarters. However, the average five-day post-earnings move is only 0.46%, indicating that these beats are often priced in and the stock frequently drifts flat afterward.
What supports AMETEK’s 20.0% net margin and 14.5% ROE?
The margin and return metrics are supported by a portfolio of specialized, specification-critical products across aerospace, defense, medical, power and automation markets, together with an operational-excellence program and tuck-in acquisitions that expand capability in adjacent niches.
What macro risks should investors monitor with AME?
Key risks include global industrial capital spending, aerospace and defense budgets, currency translation on roughly half of sales, changes in trade or tariff policy, and supply-chain or regulatory developments tied to its manufacturing footprint in China, Czechia, Malaysia, Mexico and Serbia.
For a deeper dive into how institutional analysts are modeling revenue, margins and the next earnings catalyst, readers should look at the full institutional verdict for AMETEK rather than relying on headline numbers alone.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-08-04 | $2.09 | $1.99 | +5% | +0.28% | +0.89% |
| 2026-04-30 | $1.97 | $1.9 | +3.7% | -2.13% | -0.33% |
| 2026-02-03 | $2.01 | $1.94 | +3.6% | -0.48% | +1.83% |
| 2025-10-30 | $1.89 | $1.76 | +7.4% | +1.91% | -0.54% |
| 2025-07-31 | $1.78 | $1.69 | +5.3% | - | - |
| 2025-05-01 | $1.75 | $1.69 | +3.6% | - | - |
Previous AME editions
Get the institutional verdict on AME
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the AME verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.